Tag: Ampio Pharmaceuticals

New Advances on Clinical Trial for COVID-19

Reading Time: 2 minutesAmpio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, provides updates regarding the following clinical trials: Ampion Phase I clinical trial for intravenous (“IV”) treatment of COVID-19 patients:The initial safety Read more…

Contact articles@usabusinessradio.net
for more information on articles on this site. bmuyco@usabusinessradio.net for all other information.

What Do You Do With an “Unsellable” Business?
Weekly News Wrap-Up: IRS, ETH, Mergers & More from the Price of Business Network- July 17th, 2026
The Night Shift Nobody Applied For
Redefining Restructuring: Why Current U.S. Job Cuts Feel Different
Weekly News Wrap-Up: Jobs, Leadership, Mergers & More from the Price of Business Network- July 10th, 2026

The author of the best selling finance book of all time celebrates its 20th anniversary in a series of interviews with Kevin Price on the Price of Business.

Kevin Price, Editor at Large of Daily Business Journal and host of the nationally syndicated Price of Business show writes frequently at Quora about issues ranging from politics to personality types. His favorite answers are also found at USA Business Radio.

Tag: Ampio Pharmaceuticals

New Advances on Clinical Trial for COVID-19

Celebrating 25 Years of the Price of Business Show

VIDEO: This Week’s Best of our Network

USABR: Nationally Syndicated Radio Distribution

Contact

Recent Stories in DBJ

Kevin Price’s “New Rich” Book Ready for Pre-order for 99 cents!

The Price of Business Visits with Robert Kiyosaki on 20 Years of “Rich Dad Poor Dad”

Also in DBJ

Adventures in Quora with Kevin Price

Privacy Policy